At TESARO, collaboration plays a vital role in our approach to care. We value other perspectives and believe that they are invaluable in helping us discover treatment advancements that improve lives. To that end, we seek partners interested in furthering our global mission to responsibly develop best-in-class treatments for people with various types of cancer.
Major goals for our preclinical and translational research program include applying mechanisms of action of new medicines, discovering and applying novel biomarkers to identify patients most likely to benefit from treatment, and applying logical new combination treatments for people with advanced cancers.
Preclinical submissions can be submitted at any time and are reviewed on a monthly basis.